设为首页 电子邮箱 联系我们

本刊最新招聘信息请见“通知公告”!  本刊投稿系统试运行中,欢迎投稿!如投稿有问题,可直接将稿件发送至zgyy8888@163.com

 

主管单位:中华人民共和国   

国家卫生健康委员会

总编辑:杨秋

编辑部主任:吴翔宇

邮发代号:80-528
定价:30.00元
全年:360.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)

                  

过刊目录

2026 年第 4 期 第 21 卷

环孢素A联合槐杞黄颗粒中西医结合治疗再生障碍性贫血儿童的临床效果观察

Clinical observation of cyclosporin A combined with Huaiqihuang granules in the integrated Chinese and western medicine treatment of children with aplastic anemia

作者:马旭凯1刘玉1王忠娟2海力其古丽·努日丁1赵莉1岳迎宾1李明伟1严媚1

英文作者:Ma Xukai1 Liu Yu1 Wang Zhongjuan2 Hailiqiguli Nuriding1 Zhao Li1 Yue Yingbin1 Li Mingwei1 Yan Mei1

单位:1新疆医科大学第一附属医院儿内一科,乌鲁木齐830054;2新疆医科大学第一附属医院中医综合科,乌鲁木齐830054

英文单位:1First Department of Pediatric Medicine the First Affiliated Hospital of Xinjiang Medical University Urumqi 830054 China; 2Department of Integrated Traditional Chinese Medicine the First Affiliated Hospital of Xinjiang Medical University Urumqi 830054 China

关键词:再生障碍性贫血;槐杞黄颗粒;环孢素A;T淋巴细胞亚群水平;中医证候评分

英文关键词:Aplasticanemia;Huaiqihuanggranules;CyclosporineA;Tlymphocytesubsetlevels; TraditionalChinesemedicinesyndromescore

  • 摘要:
  • 目的 观察环孢素A联合槐杞黄颗粒中西医结合治疗再生障碍性贫血(AA)儿童的临床效果。方法 收集2020年10月至2023年10月新疆医科大学第一附属医院收治的62例AA患儿的临床资料进行回顾性分析。按照治疗方案不同分为对照组(32例,接受环孢素胶囊联合司坦唑醇片口服治疗)和观察组(30例,在对照组基础上接受槐杞黄颗粒口服治疗)。比较2组临床疗效、恢复指标及治疗前后中医证候积分、血常规指标、T淋巴细胞亚群、γ干扰素水平及不良反应发生率。结果 观察组总缓解率高于对照组[96.7%(29/30)比68.8%(22/32)],就诊次数、重症感染次数、每次住院天数均明显少于对照组(均P<0.05)。治疗后观察组各项中医证候积分、CD+4、γ干扰素及辅助性T细胞17水平均低于对照组,血小板计数、血红蛋白、中性粒细胞水平均高于对照组(均P<0.05)。2组各不良反应发生率及不良反应总发生率差异均无统计学意义(均P>0.05)。结论 槐杞黄颗粒药物联合环孢素在AA患儿的临床治疗中具有较高的应用价值,可改善患者的临床症状和免疫功能,安全可靠。

  • Objective To observe the clinical efficacy of cyclosporin A combined with Huaiqihuang granules in the integrated Chinese and western medicine treatment of children with aplastic anemia (AA). Methods The clinical data of 62 children with AA admitted to the First Affiliated Hospital of Xinjiang Medical University from October 2020 to October 2023 were collected for retrospective analysis. According to different treatment regimens, the patients were divided into the control group (32 cases, treated with oral cyclosporin capsules combined with stanozolol tablets) and the observation group (30 cases, treated with oral Huaiqihuang granules on the basis of the control group). The clinical efficacy, recovery indicators, traditional Chinese medicine(TCM) syndrome scores, blood routine indicators, T lymphocyte subsets, interferon-γ levels before and after treatment, and the incidence of adverse reactions were compared between the two groups. Results The total remission rate of the observation group was higher than that of the control group [96.7%(29/30) vs 68.8%(22/32)], the number of medical visits and severe infections, the length of each hospitalization were significantly less than those of the control group (all P<0.05). After treatment, the TCM syndrome scores, CD+4, interferon-γ and T helper 17 cell levels in the observation group were lower than those in the control group, while the platelet count, hemoglobin and neutrophil levels were higher than those in the control group (all P<0.05). There were no statistically significant differences in the incidence of various adverse reactions and the total incidence of adverse reactions between the two groups (all P>0.05). Conclusion Huaiqihuang granules combined with cyclosporin A has high application value in the clinical treatment of children with AA, which can improve the clinical symptoms and immune function of patients with good safety and reliability.

copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3

当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。







安卓


苹果

关闭